This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Fulgent Genetics Securities...
Regulatory securities investigation

Fulgent Genetics Securities Investigation Initiated

Analysis based on 8 articles · First reported Mar 20, 2026 · Last updated Mar 25, 2026

Sentiment
-40
Attention
3
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market reacted negatively to Fulgent Genetics Inc.'s lower guidance, causing a significant drop in its stock price. This event could lead to a class-action lawsuit, impacting investor confidence in similar biotechnology companies.

Biotechnology Legal Services
Event Summary

Kirby McInerney LLP has launched an investigation into Fulgent Genetics Inc. following a substantial decline in its stock price. On February 27, 2026, Fulgent Genetics Inc. reported its fourth-quarter and full-year 2025 financial results and provided lower-than-expected guidance for 2026. This guidance reflected the impact of its largest customer moving a significant volume of work in-house. Consequently, Fulgent Genetics Inc.'s shares dropped by approximately 38.1%, from $24.76 to $15.33 per share. The law firm is investigating whether Fulgent Genetics Inc. and its senior management violated federal securities laws or engaged in other unlawful business practices. No lawsuit has been filed yet, and the investigation is ongoing.

Key Actions
100 Kirby McInerney LLP initiated investigation into possible securities law violations Fulgent Genetics
95 Fulgent Genetics experienced stock price decline
90 Fulgent Genetics issued lower-than-expected financial guidance
Entities Involved
stock
Fulgent Genetics
Fulgent Genetics Inc. is facing an investigation by Kirby McInerney LLP for possible violations of federal securities laws and unlawful business practices. This follows a significant drop in its stock price after providing lower-than-expected guidance for 2026, due to a major customer moving work in-house.
Importance 100 Sentiment -70
priv
Kirby McInerney LLP
Kirby McInerney LLP is conducting an investigation into Fulgent Genetics Inc. on behalf of its investors. The firm specializes in securities, antitrust, whistleblower, and consumer litigation.
Importance 80 Sentiment 10
per
Lauren Molinaro
Lauren Molinaro is an attorney at Kirby McInerney LLP and is listed as a contact for investors interested in the investigation against Fulgent Genetics Inc.
Importance 20 Sentiment 0
Relationships
Kirby McInerney LLP related ↔ Fulgent Genetics
Lauren Molinaro related ↔ Kirby McInerney LLP
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.